Joseph H. Laver, MD
Member, St. Jude Faculty
Executive Director of Domestic Affiliates and Referring Physician Office
Departments
Pediatric Medicine
Oncology
Contact Information
Joseph Laver, MD
Pediatric Medicine
MS 282, Room R3040
St. Jude Children's Research Hospital
262 Danny Thomas Place
Memphis, TN 38105-3678
Email: joseph.laver@stjude.org
Phone: (901) 595-6476
FAX: (901) 595-8600
Education
MD - Technion, Faculty of Medicine, Haifa, Israel (1977)
MHA - Medical University of South Carolina, College of Health Professionals (1996)
Honors & Awards
- 2011 America’s Top Doctors
- 1999, 2001, 2005, 2006, 2007, 2008, 2011 Best Doctors in America
- 1998, 2009, 2010 Who's Who Directory
- 1994 Mitchell I. Rubin Award
- 1986 89 American Cancer Society Career Development Award
- 1985/86 American Society of Clinical Oncology Young Investigator Award
- 1979 Technion Faculty of Medicine Graduated Cum Laude
Clinical Interests
- Pediatric stem cell transplantation
- Pediatric non-Hodgkin lymphoma
Selected Publications
Petschonek S, Burlison J, Cross C, Martin K, Laver J, Landis R, Hoffman JM. Development of the Just Culture Assessment Tool (JCAT): Measuring the Perceptions of HealthCare Professionals in Hospitals. Journal of Patient Safety 2013 (in press).
Triplett B, Wang C, Yang J, Dallas M, Hartford C, Howard V, Pillai A, Srinivasan A, Laver JH, Leung W. Outcomes after hematopoietic cell transplantation for primary immune deficiency are dependent on the use of conditioning regimens and T-cell depletion. Biol Blood Marrow Transplant Dec; 18(12):1911-20, 2012.
Shook DR, Triplett BM, Srinivasan A, Hartford C, Dallas MH, Pillai A, Laver J, Leung W. Successful Allogeneic Hematopoietic Cell Engraftment Following a Minimal Conditioning Regimen in Children with Relapsed or Refractory Solid Tumors. Biol Blood Marrow Transplant Oct; (12) 401-6, 2012.
Leung W, Pui CH, Coustan-Smith E, Yang J, Pei D, Gan K, Srinivasan A, Hartford C, Triplett BM, Dallas M, Pillai A, Shook D, Rubnitz JE, Sandlund JT, Jeha S, Ribeiro RC, Laver JH, Campana D. Minimal residual disease is prognostic but not a contraindication for hematopoietic cell transplantation in children with very-high-risk leukemia. Blood July 12; 120(2):468-72, 2012.
Thakral C, Hudson S, Shrimpton A, Barrett D, Laver J, Link M, Halleran D, Hutchison RE. ALK+ Anaplastic Large Cell Lymphoma exhibits phosphatidylinositol-3 kinase/Akt activity with retained but inactivated PTEN – A Report from the Children’s Oncology Group. Pediatr Blood Cancer September; 59(3):440-7, 2012.
Bean MK, Mazzeo SE, Stern M, Evans R, Bryan D, Ning, Y, Wickham EP, Laver JH. Six month Dietary Changes in Ethnically Diverse, Obese Adolescents Participating in a Multidisciplinary Weight Management Program. Clin Pediatr May; 50(5) 408-16, 2011.
Leung W, Campana D, Yang J, Pei D, Coustan-Smith E, Gan K, Rubnitz JE, Sandlund JT, Ribeiro RC, Srinivasan A, Hartford C, Trimplett GM, Dallas M, Pillai A, Handgretinger R, Laver JH, Pui CH. High Success of Hematopoietic Cell Transplantation Regardless of Donor Source in Children with Very-High-Risk Leukemia. Blood July 14; 118(2):223-30, 2011.
Hoffman JM, Baker DB, Howard SC, Laver JH, Shenep JL. Safe and successful implementation of CPOE for chemotherapy at a children’s cancer center. J National Comprehensive Cancer Network 9 Suppl 3:S36-50, 2011.
Kelly, N, Mazzeo, SE, Thacker LR, Evans RK, Stern M, Laver JH, Thornton L. Physical Activity, Fitness and Psychosocial Functioning of Obese Adolescents. MHPA November 18; 4:31-37, 2010.
Kalpatthi R, Peters B, Kane I, Holloman D, Rackoff E, Disco D, Jackson S, Laver JH, Abboud MR. Safety and Efficacy of High Dose Intravenous Desferrioxamine for Reduction of Iron Overload in Sickle Cell Disease. Pediatr Blood Cancer 15:55 (7) 1338-42, 2010.
Wickham EP, Stern M, Evans RK, Bryan DL, Moskowitz WB, Clore JN, Laver JH. Prevalence of the metabolic syndrome among obese adolescents enrolled in a multidisciplinary weight management program: clinical correlates and response to treatment. Metab Syndr Relat Disord 7:179-186, 2009.
Evans RK, Franco RL, Stern M, Wickham EP, Bryan DL, Herrick JE, Larson NY, Abell AM, Laver JH. Evaluation of a 6-month multi-disciplinary healthy weight management program targeting urban, overweight adolescents: effects on physical fitness, physical activity, and blood lipid profile. Int J Ped Obesity 4:130-133, 2009.
Bitsko M, Stern M, Dillon R, Russell E, Laver JH. Happiness and Time Perspective as Potential Mediators of Quality of Life and Depression in Adolescent Cancer. Pediatr Blood Cancer Mar; 50(3):613-9, 2008.
Karam LB, Disco D, Jackson SM, Lewin D, McKie V, Baker RD, Baker S, Laver JH, Nienert PJ, Abboud MR: Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels. Pediatr Blood Cancer 50:62-65, 2008.
Hutchison RE, Laver JH, Chang M, Muzzafar T, Desai S, Murphy S, Schwenn M, Shuster J, Link MP. Non-anaplastic peripheral T-cell lymphoma in childhood and adolescence: A Children’s Oncology Group Study. Pediatr Blood Cancer 51:29-33, 2008.
Nasr MR, Laver JH, Chang M., Hutchison RE. Expression of anaplastic lymphoma kinase, tyrosine-phosphorylated STAT3, and associated factors in pediatric anaplastic large cell lymphoma. A report from the Children’s Oncology Group. Am J Clin Pathol 127:770-8, 2007.
Stern M, Mazzeo SE, Gerke CK, Porter JS, Bean MK, Laver JH. Gender, Ethnicity, Psychosocial Factors and Quality of Life Among Participants in a Multidisciplinary Program Targeting Adolescent Overweight. J Pediatr Psychol 32:90-4, 2007.
Stern M, Mazzeo SE, Porter J, Gerke C, Bryant D, Laver JH. Self-esteem, Teasing and Quality of Life: African American Adolescent Girls Participating in a Family-Based Pediatric Overweight Intervention. Journal of Clinical Psychology in Medical Settings 13, 217-228, 2006.
Minamiguchi H, Wingard JR, Laver JH, Mainali ES, Shultz LD, Ogawa M. NOD-Rag1nullPrf1null mice support long-term engraftment of human hematopoietic stem cells. Biol Blood and Marrow Transplant 11:487-94, 2005.
Cairo MS, Davenport V, Bessmertny O, Goldman SC, Berg SL, Kreissman SG, Laver JH., Violet Shen, Rita Secola Carmella van deVen, Gregory H. Reaman: Phase I/II Dose Escalation Study of Recombinant Human Interleukin-11 (NEUMEGA®) Following Ifosfamide, Carboplatin, and Etoposide (ICE) in Pediatric Patients with Solid Tumors or Lymphoma: A Clinical, Hematological and Biological Study. Br J Haematol 49-58, 2005.
Laver JH, Kraveka JM, Hutchison RE, Chang M, Kepner J, Schwenn M, Tarbell N, Desai S, Weitzman S, Weinstein HJ, Murphy SB. Advanced-stage large-cell lymphoma in children and adolescents: results of a Pediatric Oncology Group randomized phase III trial. J Clin Oncol 20;23:541-7, 2005.
Godder K, Eapen M, Laver JH, Zhang M-J, Camitta B, Chen A, Doyle J, Edwards J, Gale RP, Garvin J, Sandler E, Wayne A, Yeager A, Yu L, Horowitz MM. Variables Correlated with Outcome of Autologous Blood Cell or Bone Marrow Transplants in Children with Acute Myelogenous Leukemia in first or 2nd Remission. Journal Clinical Oncology 22:3798-3804, 2004.
Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, Abboud MR. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 99:3144-50, 2002.
Abu-Ghosh A, Krailo M, Goldman S, Slack RS, davenport V, Morris E, Laver J, Reaman GH, Cairo MS. Ifosfamide, Carboplatin, and Etoposide (ICE) in Children with poor risk relapsed Wilms Tumor: A Childrens Cancer Group Report. Ann Oncol 13:460-9, 2002.
Tajima F, Deguchi T, Laver JH, Zeng H, Ogawa M, Reciprocal Expression of CD38 and CD34 by Adult Murine Hematopoietic Stem Cells. Blood 97:2618-24, 2001.
Laver JH, Hulsey TC, Jones JP, Gautreaux M, Barredo JC, Abboud MR: Assessment of Barriers to Bone Marrow Donation by Unrelated African-American Potential Donors. Biology of Blood and Marrow Transplantation 7:45-48 2001.
Laver J, Mahmoud HH, Pick TE, Weinstein HW, Hutchison RE, Schwenn M, Weitzmann S, Murphy SB, Ochoa S, Shuster JJ. Results of a Randomized Phase III Trial in Children and Adolescents with Advanced Stage Diffuse Large Cell Non Hodgkin's Lymphoma; A Pediatric Oncology Group Study. Leukemia and Lymphoma 42:399-405, 2001.
Ogawa M, Tajima F, Ito T, Sato T, Laver JH, Deguchi T. CD34 expression by murine hematopoietic stem cells; Developmental changes and kinetic alterations. Ann NY Acad Sci 938:139-45, 2001.
Last update: February 2013